Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium‐glucose co‐transporter‐2, in people with type 2 diabetes mellitus
2019 ◽
Vol 22
(2)
◽
pp. 191-202
◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽
2019 ◽